Methods for providing testosterone and optionally estrogen replacement therapy to women
Patent 5460820 Issued on October 24, 1995. Estimated Expiration Date: 
August 3, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 3, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesTransdermal estrogen/progestin dosage unit, system and process Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels Patent #: 5152997 InventorsApplicationNo. 099923 filed on 08/03/1993US Classes:424/449, Transdermal or percutaneous424/448Pressure sensitive adhesive meansExaminersPrimary: Phelan, D. GabrielleAttorney, Agent or FirmInternational ClassA61F 013/00AbstractA method of providing testosterone replacement therapy to a woman in need of such therapy comprising applying a testosterone-delivering patch to the skin of said woman which patch transdermally delivers 50 to 500 μg/day of testosterone to the woman.Other References
| |
